Pioneering the Longevity Revolution
TRANSFORMING SYSTEMIC INFLAMMATION ~ THE BIOLOGY BEHIND MOST ALL disease ~ with FIRST-In-CLASS immuno-regulators.
Inflammation underlies more than 75% of modern disease. Yet today’s treatments are late, reactive, and narrow—delivering limited benefit at immense cost. Keeping the gap between lifespan and healthspan at an all time high.
At Sen-Jam, we combine deep biology with AI-driven insights to accelerate solutions that rewrite this story. Our PAIR immuno-regulator platform applies a simple but powerful therapeutic logic: address inflammation at its biological root with unmatched safety, scalability, and accessibility.
By directly modulating the immune system—rather than chasing symptoms—we are defining a new class of medicine. One that bridges prevention, longevity, and recovery. One that extends healthspan while reducing the crushing global burden of chronic disease.
Sen-Jam isn’t just improving care. We’re reframing how the world thinks about health itself—turning immuno-regulation into the foundation of the next era in preemptive healthcare.
What We Believe
We believe unchecked inflammation is the enemy—and its first spark is our call to act.
We believe health resides upstream, not when symptoms appear.
We believe the body holds innate wisdom—and medicine should honor it.
We believe modulation is more elegant than suppression.
We believe health span is the new standard.
We don’t do sick-care. We end it.
What If We’ve Been Solving the Wrong Problem?
For decades, medicine has chased symptoms—while unchecked inflammation quietly drives disease from the inside out. Discover how one Pharmacist’s bedside insight sparked a new path forward.
A Trillion-Dollar Lever for Global Health
When you resolve inflammation at its source, you don’t just ease symptoms—you alter the course of disease itself. The ripple effect is profound: reduced suffering, extended healthspan, and a rebalanced healthcare economy.
Sen-Jam’s PAIR platform is designed to unlock this shift. Our lead assets target four of the world’s most devastating and costly health burdens—conditions that collectively drain trillions from societies and economies every year.
By moving upstream, we’re not only redefining how these diseases are treated, but also transforming the very economics of global health.
Metabolic Overload (overeating, obesity, alcohol-related stress)
$4.3 trillion—projected 3% of global GDP by 2035
The world’s most costly daily habit—reshaping metabolism, accelerating disease.
Opioid Crisis (withdrawal, dependence, tolerance)
$2.7 trillion U.S. impact in 2023 alone
A trillion-dollar hemorrhage—where safer, inflammation-driven, non-opioid solutions are urgently needed.
Respiratory Infections (COPD, URIs, COVID, RSV)
#3 global cause of death; 3.2 million COPD deaths/year
Every breath carries a toll—where unchecked inflammation turns treatable illness into tragedy.
Runaway Hospital Inflammation (Sepsis, ARDS, critical-care inflammation)
11 million deaths and $52B U.S. spend per year
In the ICU, it’s the silent driver of cost, mortality, and system strain.
PAIR turns these towering costs into opportunity—quietly, elegantly, with a safety profile we are actively proving to be a mechanism ready to reshape global health.
Next—meet the combination duo unlocking this new frontier
Two Proven Molecules, One Novel Alliance
PAIR repurposes a decades-trusted NSAID and a well-characterized mast-cell modulator, tuning their ratios so they work with—rather than against—your innate immune sentinels. By soothing mast cells while dampening COX1 and COX2 in the same breath, this dynamic duo halts the inflammatory cascade upstream, turning familiar chemistry into breakthrough, tissue-sparing relief.
When one elegant alliance can be tuned like a dial, opportunity multiplies fast. Scroll on to see how the same PAIR blueprint is already branching into eleven tailored programs—some headed for the pharmacy aisle, others for the ICU—all advancing our pipeline.
Therapeutic Pipeline
Addressing Significant Unmet Needs with a Revolutionary Combination Immuno-Inflammatory Portfolio
Prescription Strength Relief
Prescription Strength Relief
Over the Counter Relief
Over the Counter ReliefUpper Respiratory Infections, including COVID
Obesity/MASH
Metabolic Recovery (food and alcohol)
Opioid Use Disorder
Vaccination Side-effects
Respiratory Common Cold
Arthritis
Premature Aging
Prescription Strength Relief
Over the Counter Relief
COVID-19/URI
Adverse Effects of Alcohol
OPIOID USE DISORDER
VACCINATION SIDE-EFFECTS
UPPER RESPIRATORY INFECTIONS
ARTHRITIS
Premature Aging
World-Class Expertise Driving a New Standard of Care
Our leadership, scientific advisors, and collaborators draw on experience and active engagements across many of the world’s most respected institutions—helping bring Sen-Jam’s vision to the forefront of inflammation science and translational medicine.
Rewriting the Future of Inflammatory Care
Be part of a new chapter in medicine—where upstream solutions preserve healthspan, transform outcomes, and redefine the economics of disease.
